title: Toluene-induced hearing loss in acivicin-treated rats.
abstract: Toluene can be considered an ototoxic chemical compound in the rat. Outer hair cells are particularly sensitive to this aromatic organic solvent or to one of its metabolites. The objective of the present study was to evaluate the possible role played by cysteine S-conjugates in the ototoxic process in Long-Evans rats. To this end, renal and hepatic metabolism of toluene was modified by treatment with acivicin, an inhibitor of gamma-glutamyl transferase (gamma-GT). First, the efficacy of the acivicin treatment was established from a dose-response investigation in which urinary gamma-GT was measured daily in rats exposed to 1750 ppm toluene, 6 h per day for five days. A twice weekly 5 mg/kg dose was reduced urinary gamma-GT by 70-78%. In a subacute experiment, rats were exposed to 1750 ppm toluene for four consecutive weeks, in which the efficacy of the acivicin treatment was monitored by quantifying the urinary end product of the conjugate pathway: benzyl mercapturic acid (BMA). A 38.5% decrease in BMA was measured at the end of the exposure period. Hearing impairment was evaluated using auditory (inferior colliculus) evoked potentials and completed with conventional histological approaches. The toluene-exposed and the acivicin-treated rats exposed to toluene both had a 7-dB permanent auditory threshold shift at 16-20 kHz. Hair cell loss was not dependent on acivicin treatment. Therefore, the partial inhibition of gamma-GT did not modify the toluene ototoxicity, suggesting that toluene-induced hearing loss is not strongly mediated by the production of cysteine S-conjugates. However, the data do not rule out the possibility that these metabolites may play a minor role.
authors.affiliation: Institut National de Recherche et de Sécurité, Département Polluants et Santé Avenue de Bourgogne, BP 27 Vandoeuvre, 54501 cédex, France.
authors.forename: Delphine
authors.initials: D
authors.lastname: Waniusiow
authors.forename: Pierre
authors.initials: P
authors.lastname: Campo
authors.forename: Benoît
authors.initials: B
authors.lastname: Cossec
authors.forename: Frédéric
authors.initials: F
authors.lastname: Cosnier
authors.forename: Stephane
authors.initials: S
authors.lastname: Grossman
authors.forename: Luc
authors.initials: L
authors.lastname: Ferrari
mesh_terms: D000111:Acetylcysteine / Q000031:analogs & derivatives / Q000652:urine; D000818:Animals; D000963:Antimetabolites / Q000633:toxicity*; D001299:Audiometry; D003545:Cysteine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D006311:Hearing Disorders / Q000139:chemically induced*; D006626:Hippurates / Q000097:blood; D007555:Isoxazoles / Q000633:toxicity*; D008297:Male; D051381:Rats; D020318:Rats, Long-Evans; D014050:Toluene / Q000097:blood / Q000633:toxicity*; D005723:gamma-Glutamyltransferase / Q000378:metabolism
chemical_list: D000963:Antimetabolites; D006626:Hippurates; D007555:Isoxazoles; D014050:Toluene; D005723:gamma-Glutamyltransferase; D003545:Cysteine; C006303:acivicin; C030514:hippuric acid; D000111:Acetylcysteine; C029319:S-benzyl-N-acetyl-L-cysteine